DK1151005T3 - Peptidvarianter af tumormarkør MUC1 og deres anvendelse - Google Patents

Peptidvarianter af tumormarkør MUC1 og deres anvendelse

Info

Publication number
DK1151005T3
DK1151005T3 DK00916753T DK00916753T DK1151005T3 DK 1151005 T3 DK1151005 T3 DK 1151005T3 DK 00916753 T DK00916753 T DK 00916753T DK 00916753 T DK00916753 T DK 00916753T DK 1151005 T3 DK1151005 T3 DK 1151005T3
Authority
DK
Denmark
Prior art keywords
peptide variants
tumor marker
muc1
marker muc1
refers
Prior art date
Application number
DK00916753T
Other languages
Danish (da)
English (en)
Inventor
Franz-Georg Hanisch
Stefan Mueller
Original Assignee
Cell Ct Cologne Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Ct Cologne Gmbh filed Critical Cell Ct Cologne Gmbh
Application granted granted Critical
Publication of DK1151005T3 publication Critical patent/DK1151005T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00916753T 1999-02-17 2000-02-17 Peptidvarianter af tumormarkør MUC1 og deres anvendelse DK1151005T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19906615A DE19906615A1 (de) 1999-02-17 1999-02-17 Peptid-Varianten des Tumormarkers MUC1 und ihre Verwendung
PCT/DE2000/000440 WO2000049045A1 (de) 1999-02-17 2000-02-17 Peptid-varianten des tumormarkers muc1 und ihre verwendung

Publications (1)

Publication Number Publication Date
DK1151005T3 true DK1151005T3 (da) 2003-10-13

Family

ID=7897778

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00916753T DK1151005T3 (da) 1999-02-17 2000-02-17 Peptidvarianter af tumormarkør MUC1 og deres anvendelse

Country Status (10)

Country Link
US (1) US20090054622A1 (enExample)
EP (1) EP1151005B1 (enExample)
JP (1) JP2002541067A (enExample)
AT (1) ATE243222T1 (enExample)
AU (1) AU772709B2 (enExample)
CA (1) CA2368309A1 (enExample)
DE (2) DE19906615A1 (enExample)
DK (1) DK1151005T3 (enExample)
ES (1) ES2200851T3 (enExample)
WO (1) WO2000049045A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003266236A1 (en) 2002-07-22 2004-02-09 Nemod Immuntherapie Ag Method for the production of an immunostimulating mucin (muc1)
US9346867B2 (en) 2010-04-19 2016-05-24 Sumitomo Bakelite Co., Ltd. Cancer-related glycopeptide epitopes, antibodies and methods of use
KR102049928B1 (ko) 2011-08-17 2019-11-28 글로브이뮨 효모-muc1 면역요법 조성물 및 그 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3023469B2 (ja) * 1992-02-21 2000-03-21 株式会社日本抗体研究所 糖タンパク質３９遺伝子
US6120765A (en) * 1993-04-02 2000-09-19 Shiseido Co. Ltd. Urokinase plasminogen activator fragments
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
AU727308B2 (en) * 1997-02-24 2000-12-07 Dana-Farber Cancer Institute Recombinant pox virus for immunization against muc1 tumor-associated antigen

Also Published As

Publication number Publication date
ATE243222T1 (de) 2003-07-15
DE50002584D1 (de) 2003-07-24
CA2368309A1 (en) 2000-08-24
AU772709B2 (en) 2004-05-06
EP1151005A1 (de) 2001-11-07
ES2200851T3 (es) 2004-03-16
JP2002541067A (ja) 2002-12-03
AU3801300A (en) 2000-09-04
US20090054622A1 (en) 2009-02-26
DE19906615A1 (de) 2000-09-28
EP1151005B1 (de) 2003-06-18
WO2000049045A1 (de) 2000-08-24

Similar Documents

Publication Publication Date Title
CY2016021I1 (el) Στελεχη ιων για την ογκολυτικη θεραπεια του καρκινου
NL300415I1 (nl) Vaccin tegen antigenen van bacteriën
CY1109741T1 (el) Sns-595 και μεθοδοι χρησης αυτου
DZ2462A1 (fr) Vaccin antigrippal.
CY1113347T1 (el) Πεπτιδια που μειωνουν τα επιπεδα της γλυκοζης στο αιμα
DK1210113T3 (da) Kombinerede vaccinepræparater
EP1307130A4 (en) VACCINE AGAINST THE VIRUS OF HUMAN IMMUNODEFICIENCY
NO992102D0 (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
AU2273701A (en) Hla class i a2 tumor associated antigen peptides and vaccine compositions
DZ3219A1 (fr) Vaccin
DE60330708D1 (de) Impfstoff gegen das west-nile-virus
EP1423141A4 (en) VACCINE
FI20011671A0 (fi) Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
CY1112658T1 (el) Εμβολια τα οποια περιεχουν αντιγονο μαgε συνδεομενο με θραυσμα πρωτεϊνης d
DK0876398T3 (da) Induktion af immunrespons med ønskede determinanter
EP1462456A4 (en) TUMOR ANTIGENS
DE60006245D1 (de) Festigungsvorrichtung
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
DK1151005T3 (da) Peptidvarianter af tumormarkør MUC1 og deres anvendelse
DE69723580D1 (de) Impfstoff gegen metastasierenden kolorektalkrebs.
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
IT1309584B1 (it) Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.
DE10290185D2 (de) Tumorvakzine
UY26170A1 (es) Antigeno (c42) asociados a tumores
IS5829A (is) Peptíðbrot úr kólerutoxíni B eða iðratoxíni B semhjálparefni í bóluefni